Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,629 | 68,740 | 86,327 | 94,386 | 95,817 |
| Marketable Securities | N/A | N/A | N/A | N/A | 2,501 |
| Receivables | 23,594 | 26,360 | 34,627 | 29,843 | 24,102 |
| Inventories | 23,809 | 24,428 | 39,765 | 36,010 | 46,209 |
| Other current assets | 5,126 | 36,305 | 0 | 0 | 0 |
| TOTAL | $113,652 | $163,309 | $169,547 | $168,528 | $177,383 |
| Non-Current Assets | |||||
| PPE Net | 38,994 | 37,445 | 48,279 | 47,602 | 50,613 |
| Intangibles | 9,615 | 10,147 | 81,938 | 90,163 | 99,570 |
| Other Non-Current Assets | 40,479 | 59,731 | 49,364 | 41,242 | 38,039 |
| TOTAL | $89,088 | $107,323 | $179,581 | $179,007 | $188,222 |
| Total Assets | $202,740 | $270,632 | $349,128 | $347,535 | $365,605 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,617 | 6,194 | 9,074 | 7,633 | 8,984 |
| Accrued Expenses | 13,567 | 14,066 | 18,840 | 17,847 | 14,793 |
| Other current liabilities | 4,122 | 10,799 | N/A | 4,315 | 13,090 |
| TOTAL | $23,306 | $31,059 | $27,914 | $29,795 | $36,867 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,445 | 27,308 | 29,215 | 20,498 | 44,443 |
| TOTAL | $25,445 | $27,308 | $35,651 | $30,655 | $56,338 |
| Total Liabilities | $48,751 | $58,367 | $63,565 | $60,450 | $93,205 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,176 | 14,850 | 14,633 | 14,467 | 14,330 |
| Common Shares | 144 | 147 | 146 | 144 | 143 |
| Retained earnings | 71,667 | 128,052 | 210,719 | 225,578 | 221,444 |
| Other shareholders' equity | -6,783 | -5,943 | -6,443 | -5,718 | -4,542 |
| TOTAL | $153,989 | $212,265 | $285,563 | $287,085 | $272,400 |
| Total Liabilities And Equity | $202,740 | $270,632 | $349,128 | $347,535 | $365,605 |